Stay updated on PATHWay Study: Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedSite revision updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check26 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3; no visible changes to study content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now displays a new revision label 'Revision: v3.4.2', and the prior general funding/operating status notice was removed. These are administrative changes that do not affect the study content, eligibility criteria, or outcomes.SummaryDifference0.5%

- Check61 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status, with guidance to visit cc.nih.gov and opm.gov; updated the revision tag to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check69 days agoChange DetectedThe page now displays new metadata fields: 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', and shows 'No FEAR Act Data' along with Revision: v3.4.0. The previous fields were 'Last Update Submitted that met QC Criteria', 'Last Update Posted (Estimated)', 'No FEAR Act data', and Revision: v3.3.4, which have been removed.SummaryDifference0.3%

- Check76 days agoChange DetectedPage revision updated to v3.3.4 from v3.3.3; this appears to be a metadata/version update with no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PATHWay Study: Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PATHWay Study: Adjuvant Pembrolizumab Clinical Trial page.